ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: Chicago

Baxter’s Alzheimer’s disease drug fails in late-stage trial

Baxter’s Alzheimer’s disease drug fails in late-stage trial

May 7, 2013 7:31 am by | 0 Comments

(Reuters) - Baxter International Inc said a late-stage study of its experimental drug to treat Alzheimer's disease failed to reduce the decline of cognitive functions and preserve functional abilities.The trial ... Read more
Nurses go back to school to get their bachelor’s degree

Nurses go back to school to get their bachelor’s degree

May 1, 2013 3:05 am by | 0 Comments

Anne Lipira had been thriving as a nurse at a west suburban hospital when she decided to go back to school in 2011 to get a higher degree in the ... Read more
U.S.-backed HIV vaccine fails; study halted

U.S.-backed HIV vaccine fails; study halted

April 25, 2013 12:43 pm by | 0 Comments

CHICAGO (Reuters) - The National Institutes of Health has halted a study testing an experimental HIV vaccine after an independent review board found the vaccine did not prevent HIV infection ... Read more
Questions over gene patents shake diagnostics industry

Questions over gene patents shake diagnostics industry

April 24, 2013 12:00 am by | 0 Comments

The impending Supreme Court ruling on gene patents is creating uncertainty in the fledging genetic diagnostics sector. At this week’s Biotechnology Industry Organization show in Chicago, a panel of law ... Read more
Humana says internal review started after private Medicare leak

Humana says internal review started after private Medicare leak

April 18, 2013 8:05 pm by | 0 Comments

(Reuters) - Health insurer Humana Inc said on Thursday that it has begun an internal review of the events around an announcement on April 1 of a government policy change ... Read more
Drug pipeline for worst superbugs “on life support”: report

Drug pipeline for worst superbugs “on life support”: report

April 18, 2013 12:09 am by | 0 Comments

CHICAGO (Reuters) - Only seven new drugs are in development for the treatment of infections caused by an especially nasty class of superbugs that include E. coli and CRE, the ... Read more
Sales, profit jump at ‘new’ Abbott

Sales, profit jump at ‘new’ Abbott

April 17, 2013 11:29 am by | 0 Comments

Abbott Laboratories, in its first quarterly earnings report without its proprietary pharmaceutical arm, said first-quarter net income from its continuing operations rose 55 percent to $544 million, or 34 cents ... Read more
Illinois jury finds in favor of J&J in hip implant trial

Illinois jury finds in favor of J&J in hip implant trial

April 16, 2013 7:30 pm by | 0 Comments

April 16 (Reuters) - An Illinois jury on Tuesday found in favor of Johnson & Johnson's DePuy unit in a product liability lawsuit involving the company's ASR hip implant, J&J ... Read more
Walgreens becomes 1st retail chain to diagnose, treat chronic conditions

Walgreens becomes 1st retail chain to diagnose, treat chronic conditions

April 4, 2013 5:47 am by | 0 Comments

It’s not just sore throats and flu shots anymore. Walgreens today became the first retail store chain to expand its health care services to include diagnosing and treating patients for ... Read more
Experimental sleep drug may cause fewer side effects: Merck study

Experimental sleep drug may cause fewer side effects: Merck study

April 3, 2013 3:12 pm by | 0 Comments

CHICAGO (Reuters) - A study in rats and monkeys suggests an experimental Merck & Co sleep drug may help induce sleep without causing the memory loss and attention problems sometimes ... Read more
FDA advisers vote for approval of Abbott’s implantable heart device

FDA advisers vote for approval of Abbott’s implantable heart device

March 20, 2013 9:14 pm by | 0 Comments

(Reuters) - A slim majority of advisers to the U.S. Food and Drug Administration voted on Wednesday for approval of Abbott Laboratories' implantable heart device MitraClip, saying it had more ... Read more
Compensation jumps 43% for AbbVie CEO

Compensation jumps 43% for AbbVie CEO

March 19, 2013 4:58 am by | 0 Comments

Richard Gonzalez' final year at Abbott Laboratories was a lucrative one.The CEO of AbbVie Inc., the North Chicago-based pharmaceutical company spun off from Abbott on Jan. 1, received a 43 ... Read more
FDA staff does not recommend approval of Abbott’s heart device

FDA staff does not recommend approval of Abbott’s heart device

March 18, 2013 10:05 am by | 0 Comments

(Reuters) - Staff reviewers for the Food and Drug Administration did not recommend approval of Abbott Laboratories' implantable heart device MitraClip, citing a lack of "valid scientific evidence" of safety ... Read more
New healthcare accelerator to play matchmaker for hospitals, partners with HIMSS

New healthcare accelerator to play matchmaker for hospitals, partners with HIMSS

March 4, 2013 12:54 pm by | 0 Comments

A new healthcare accelerator that will focus solely on connecting promising early stage companies with health systems has struck a partnership with HIMSS, has started scouting companies and will announce ... Read more
$11M round will fund Novian’s trial of laser- based minimally invasive breast cancer device

$11M round will fund Novian’s trial of laser- based minimally invasive breast cancer device

February 5, 2013 10:56 am by | 0 Comments

To help fund clinical trials of a minimally invasive, laser-based breast cancer therapy, Novian Health Inc. has rounded up $11 million from investors.The Series A, led by iNetworks LLC, will ... Read more